跳至主要内容
临床试验/IRCT2016060612782N11
IRCT2016060612782N11已完成未知

Evaluation of therapeutic effects of single and divided dose of piracetam in patients with breath holding spells

Vice Chancellor for research of Isfahan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 months 至 3 years(—)
性别
All

入选标准

  • Inclusion criteria for the study included as follows:
  • Age of 6 months to three years; Frequent seizures, more than two times a week; Severe seizures that lead to loss of consciousness
  • Exclusion criteria included as follows:
  • History of seizures; History of heart disease; Anemia (hemoglobin less than 10.5)

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research of Isfahan University of Medical Sciences

相似试验